세계의 미생물 분석기 시장 - 산업 규모, 점유율, 동향, 기회, 예측, 유형별, 제품별, 용도별, 최종 사용자별, 지역별, 경쟁별(2020-2030년)
Microbiology Analyzers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Product, By Application, By End User, By Region & Competition, 2020-2030F
상품코드:1785161
리서치사:TechSci Research
발행일:2025년 08월
페이지 정보:영문 190 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
미생물 분석기 세계 시장 규모는 2024년에 9억 8,250만 달러에 이르렀으며, 2030년 CAGR은 6.68%를 나타내고 예측 기간 동안 눈부신 성장을 이룰 것으로 예측되고 있습니다.
미생물 분석기는 박테리아, 바이러스, 곰팡이, 기생충과 같은 미생물을 검출, 확인, 특성화하기 위해 특별히 설계된 고급 검사 장치입니다. 이러한 분석 장비는 전통적으로 시간이 많이 걸리는 수동 작업이 필요한 주요 프로세스를 자동화하여 미생물 검사의 효율성과 정확성을 크게 향상 시켰습니다. 미생물 분석기는 질량분석, 중합효소 연쇄반응(PCR), 형광, 분광광도법 등의 기술을 이용하여 신속하고 신뢰할 수 있는 결과를 기재하고 있습니다. 이 기능은 적시에 진단이 환자 결과 또는 치료 정책 결정에 직접 영향을 미치는 임상 현장에서 매우 중요합니다. 임상 실험실에서 미생물 분석기는 감염의 진단, 아웃 브레이크 모니터링, 항균제 관리 프로그램 지원에 필수적인 도구입니다. 미생물 분석기는 병원체를 확인하고 다양한 항생제에 대한 감수성을 결정함으로써 표적 치료를 가능하게 하고 항생제 내성의 위험을 감소시킵니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
9억 8,250만 달러
시장 규모 : 2030년
14억 3,656만 달러
CAGR : 2025-2030년
6.68%
급성장 부문
자동 분석기
최대 시장
북미
시장 성장 촉진요인
STD 및 기타 질병 증가
주요 시장 과제
개발 도상 지역에서의 상환 제한
주요 시장 동향
미생물 검사와 관련된 전략적 제품 상시 증가
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 목소리
제5장 세계의 미생물 분석기 시장 전망
시장 규모와 예측
금액별
시장 점유율 및 예측
유형별(자동 분석 장치, 임상 분석 장치, 분자 분석 장치, 전자동 분석 장치)
제품별(분자진단 기기, 현미경, 질량 분석계, 기타)
용도별(미생물 감염, 항생물질 감수성, 소변 검사, 혈액 배양, 기타)
최종 사용자별(병원, 진단센터, 커스텀 랩 서비스 제공업체, 학술 연구 기관)
지역별
기업별(2024년)
시장 맵
제6장 북미의 미생물 분석기 시장 전망
시장 규모와 예측
시장 점유율 및 예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 미생물 분석기 시장 전망
시장 규모와 예측
시장 점유율 및 예측
유럽 : 국가별 분석
독일
영국
이탈리아
프랑스
스페인
제8장 아시아태평양의 미생물 분석기 시장 전망
시장 규모와 예측
시장 점유율 및 예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 남미의 미생물 분석기 시장 전망
시장 규모와 예측
시장 점유율 및 예측
남미 : 국가별 분석
브라질
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 미생물 분석기 시장 전망
시장 규모와 예측
시장 점유율 및 예측
중동 및 아프리카 : 국가별 분석
남아프리카
사우디아라비아
아랍에미리트(UAE)
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
제13장 세계의 미생물 분석기 시장 : SWOT 분석
제14장 경쟁 구도
Thermo Fisher Scientific Inc.
Sigma-Aldrich Corporation
Danaher Corporation
Merck KGaA
Bio-Rad Laboratories, Inc.
bioMerieux Inc.
QIAGEN NV
F. Hoffmann-La Roche AG
Abbott Laboratories Ltd.
Ortho Clinical Diagnostics Inc.
제15장 전략적 제안
제16장 기업 소개와 면책사항
SHW
영문 목차
영문목차
Global Microbiology Analyzers Market was valued at USD 982.50 Million in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.68% through 2030F. A microbiology analyzer is an advanced laboratory instrument specifically engineered to detect, identify, and characterize microorganisms such as bacteria, viruses, fungi, and parasites. These analyzers significantly enhance the efficiency and accuracy of microbiological testing by automating key processes, which traditionally required time-consuming manual techniques. Utilizing technologies such as mass spectrometry, polymerase chain reaction (PCR), fluorescence, and spectrophotometry, microbiology analyzers provide rapid and reliable results. This capability is critical in clinical settings where timely diagnosis can directly influence patient outcomes and treatment decisions. In clinical laboratories, microbiology analyzers are indispensable tools for diagnosing infectious diseases, monitoring outbreaks, and supporting antimicrobial stewardship programs. They help in identifying pathogens and determining their susceptibility to various antibiotics, enabling targeted therapies and reducing the risk of antibiotic resistance.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 982.50 Million
Market Size 2030
USD 1436.56 Million
CAGR 2025-2030
6.68%
Fastest Growing Segment
Automated Analyzers
Largest Market
North America
Key Market Drivers
Growing Cases of STD and Other Diseases
The significant rise in the incidence of sexually transmitted diseases necessitates the prompt utilization of microbiology testing. For instance, according to the WHO 2024 report, there has been a significant rise in sexually transmitted infections (STIs) globally. The report also highlights ongoing challenges in combating HIV and hepatitis, emphasizing the urgent need for strengthened public health responses, improved access to diagnostics and treatment, and greater awareness to curb the growing burden of these infectious diseases. As per the World Health Organization's published data, over 1 million sexually transmitted infections are contracted globally each day, with the majority of cases expected to be asymptomatic in 2022. The report also indicates an annual occurrence of approximately 374 million new infections, with chlamydia, trichomoniasis, gonorrhea, and syphilis accounting for one in four sexually transmitted infections. These diseases require immediate testing to identify the responsible viruses for expedited treatment processes. Microbiology analyzers can rapidly and accurately detect the presence of STD-causing microorganisms, such as bacteria, viruses, and parasites. Early detection is crucial for timely treatment and preventing the spread of infections, especially in cases of asymptomatic or mild symptoms. Many microbiology analyzers offer multiplex testing capabilities, which means they can detect multiple STD pathogens in a single sample. This is especially beneficial for detecting co-infections or identifying multiple pathogens contributing to similar symptoms. Consequently, this factor contributes to the growth of the market.
Key Market Challenges
Limited Reimbursement in Developing Regions
In numerous countries, delayed reimbursement poses a significant obstacle to market expansion. The process of reimbursing microbiology testing is intricate and convoluted. The complexity of this reimbursement process serves as a major impediment to market growth. The absence of standardized reimbursement policies in several countries hinders the progress of the market. The lack of standardized reimbursement policies across different countries or regions can create confusion and barriers to market entry. Varying reimbursement rates, criteria, and procedures can make it difficult for manufacturers and healthcare providers to navigate the reimbursement landscape effectively. Consequently, the lack of reimbursement in emerging nations severely hampers market growth. Delays in reimbursement can create financial uncertainties for healthcare providers and laboratories. When reimbursement for microbiology testing is slow or unpredictable, it can discourage investment in advanced testing equipment and technologies. This can lead to underutilization of modern microbiology analyzers and hinder their market expansion.
Key Market Trends
Increasing Strategic Product Launches Associated with Microbiology Testing
The increasing prevalence of infectious diseases and various strategies implemented by key market players, such as product launches and service expansions, are expected to drive the growth of the Microbiology Analyzers market. For example, in 2022, STEMart introduced microbiology and sterility testing for both sterile and non-pyrogenic medical devices. As a result, the growing number of services launches by major market players is projected to enhance market growth throughout the forecast period. New product launches often introduce advanced technologies, improved features, and enhanced capabilities. This can attract the attention of healthcare providers, researchers, and laboratories looking to upgrade their testing equipment to stay at the forefront of diagnostic and research capabilities. Strategic product launches can address accuracy concerns and offer enhanced precision in microbial testing. Improved accuracy leads to more reliable results and higher confidence in the testing process, which in turn drives demand. New product offerings might streamline testing workflows, reduce turnaround times, and increase laboratory efficiency. This can be particularly appealing in high-volume settings where rapid and efficient testing is crucial. Consequently, this factor contributes to the advancement of the market.
Key Market Players
Thermo Fisher Scientific Inc.
Sigma-Aldrich Corporation
Danaher Corporation
Merck KGaA
Bio-Rad Laboratories, Inc.
bioMerieux Inc.
QIAGEN N.V.
F. Hoffmann-La Roche AG
Abbott Laboratories Ltd.
Ortho Clinical Diagnostics Inc.
Report Scope:
In this report, the Global Microbiology Analyzers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Microbiology Analyzers Market, By Type:
Automated Analyzers
Clinical Analyzers
Molecular Analyzers
Fully Automated Analyzers
Microbiology Analyzers Market, By Product:
Molecular Diagnostic Instruments
Microscopes
Mass Spectrometers
Others
Microbiology Analyzers Market, By Application:
Microbial Infection
Antibiotic Susceptibility
Urine Screening
Blood Cultures
Others
Microbiology Analyzers Market, By End User:
Hospitals & Diagnostic Centres
Custom Lab Service Providers
Academic & Research Institutes
Microbiology Analyzers Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia-Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Microbiology Analyzers Market.
Available Customizations:
Global Microbiology Analyzers market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validations
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Microbiology Analyzers Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Automated Analyzers, Clinical Analyzers, Molecular Analyzers, Fully Automated Analyzers)
5.2.2. By Product (Molecular Diagnostic Instruments, Microscopes, Mass Spectrometers, Others)
